APLT News and Press, Applied Therapeutics Inc. From 02/27/20

The investment research arm of Barclays (NYSE: BCS ,LSE:BARC) is not worried about drug pricing concerns in the US; instead, it has a positive outlook for the country’s biopharma industry. On Wednesday (February 26), Barclays Capital launched its coverage of the US biopharma space w...

NEW YORK, Feb. 26, 2020 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, announced today that it will p...

Despite mounting political pressure to drastically lower prescription drug prices in the United States, the biotech industry as a whole has performed quite well during the opening weeks of 2020. The long and short of it is that investors are still fairly optimistic about biotech's long-term pros...

InsiderInsights' Daily Round Up articles rate the "Significance" of the Top 10 dollar value insider purchases and sales filed at the SEC on the Title date. Dollar value is only the most basic metric to assess the "Significance" of an insider transaction, however, and often not even the most im...

NEW YORK, Jan. 28, 2020 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (NASDAQ: APLT) (the “Company”), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today...

Applied Therapeutics (NASDAQ: APLT ) has priced its upsized public offering of 2,741,489 common shares (from 1,750,000 shares) at $45.50 per share, for expected gross proceeds of ~$124.7M. More news on: Applied Therapeutics, Inc., Healthcare stocks news, , Read more ...

NEW YORK, Jan. 23, 2020 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (NASDAQ: APLT) (the “Company”), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today...

2019 was almost  the record year for IPOs and venture capital (VC) investors. The year 2018 was No. 1 for the number of new unicorns, the total dollar amount of VC investment, and a few other metrics; 2019 came in second in many of these categories. Does this mean 2018 was the p...

Applied Therapeutics (NASDAQ: APLT ) announces a public offering of 1.75M common shares. Underwriters' over-allotment will be an additional 262.5K shares. More news on: Applied Therapeutics, Inc., Healthcare stocks news, Stocks on the move, , Read more ...

NEW YORK, Jan. 21, 2020 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (NASDAQ: APLT) (the “Company”), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today...